HOW do government organisation structure and the activities of disease control programmes affect outcomes such as mortality? According to the World Health Organization (WHO), contagious diseases no longer represent a major threat of mortality in the world; 1 however, tuberculosis (TB) still accounts for the majority of deaths caused by an infectious agent. TB not only has a severe impact in Asia, it still poses a formidable challenge to public health worldwide. 2, 3 TB causes 25% of all avoidable deaths in the economically productive age groups, 4, 5 and the TB treatment regimen is laborious and time-consuming. However, according to most previous studies, TB deaths are preventable if health authorities implement rigorous policies and if patients adhere to their treatment protocols.
Reduction in mortality is possible through various interventions such as medical treatment, health education and utilisation of disease control tools. These tools are diagnostics, drugs and vaccines, which are not 'magic bullets'. 6 In the West, the decline in the TB mortality rate was primarily due to the elimination of poverty, improved nutrition and better medical care (such as the use of streptomycin), which reduced deaths in the United Kingdom by 51% from 1948 to 1971. 7 However, TB remains a leading cause of death in low-income countries. Without adequate treatment, case fatality rates are high, over 50% within 5 to 8 years. With the availability of effective treatment, TB case fatality rates can be reduced from 50% to <5% within 5 years. [8] [9] [10] Previous research has focused on the effectiveness of treatment, 11, 12 the evaluation of interventions and the measurement of the disease burden from a clinical viewpoint. Few studies have investigated the public health perspective in health policy decision making. Some Asian countries such as Taiwan have made tremendous progress in the prevention (e.g., bacille Calmette-Guérin, X-ray screening and a computerised reporting system) and treatment of TB in the past decades. However, TB control in Taiwan faces the same predicament as in other industrialised countries. Most offi cials were optimistic in the 1980s, predicting a positive outcome in TB control based on the declining trend of incidence and mortality. However, if the TB control programme is inattentive, we may face a resurgence of TB as seen in the United States in the 1980s.
Health authorities used a centralised approach in the early (pre-1988) stage of TB control in Taiwan, at which time the Bureau of TB Prevention was responsible for TB control. In 1989, the organisational structure of TB control was absorbed into the Bureau of Chronic Disease Prevention and Treatment (CDPT). The Taiwanese government saw TB as a chronic disease and not as a major infectious disease, unlike other industrialised countries. Following a government reorganisation in 1999, the Center for Disease Control (CDC) was established, replacing the CDPT as the organisation responsible for leading antituberculosis efforts in Taiwan. Following the establishment of the CDC, clinical and public health became completely separate. The former anti-tuberculosis organisation was dismantled, and TB control became part of the Taiwan CDC, providing all Taiwanese citizens with access to TB treatment. 13 Despite this organisational change, the government budget for TB control remained steady until the launch of the national TB programme (NTP) by the CDC in 2001.
Mortality trends refl ect efforts made to improve TB control, such as the creation of a seamless process of surveillance, treatment and case management, with strong political commitment to provide funding to enable this process. The purpose of the present study was to use Joinpoint regression to analyse mortality trends with respect to organisational changes. These fi ndings will help policy makers re-examine relevant issues related to mortality rates from fi eld experiments and re-identify some useful decisions that other countries can learn from. TB control lessons in Taiwan may provide valuable information, especially regarding policy implementation and organisational changes.
METHODS
TB mortality data were extracted from the cause-ofdeath registry database maintained by the Department of Health of Taiwan. Population data were obtained from the household population registration system provided by the Ministry of the Interior of Taiwan. By law, all reported cases of death require a diagnosis of the cause of death by a qualifi ed physician responsible for fi lling out the death certifi cate; this information is then recorded in the cause-ofdeath registry, in accordance with international standards. These data were used to calculate sex-and agespecifi c TB mortality rates. Causes of death were classifi ed according to the International Classifi cation of Diseases eighth revision (ICD-8) for the period 1971-1980 and the ninth revision (ICD-9) for the period 1981-2008, including 010-018 for ICD-8 and 010-019 for ICD-9, respectively.
To allow for changes in the composition of the population, the analysis included calculating agestandardised mortality rates (ASMR) using direct standardisation based on the 2000 WHO world standard population. The ASMR is the sum of the product of mortality rate in the ith age stratum (0-4, 5-9, . . . , ⩾85 years) in a given year in Taiwan and the proportion of standard population in the same age stratum in the same year. Analyses were undertaken for all ages as well as for three specifi c age groups: <45, 45-64 and ⩾65 years. This study also analysed trends by sex to generate more information.
We conducted Joinpoint (JP) regression analyses to identify changes in TB mortality rates from 1971 to 2008 in Taiwan. The JP regression methods were originally developed to identify points of signifi cant infl ection in cancer incidence/mortality trends. 14, 15 Statistically signifi cant changes in trends can be detected and quantifi ed. The best fi tting points are chosen in the fi nal model. 16 This information assists in explaining or engendering further research on the causes of the changes in trends. The analysis begins with a minimum number of infl ections (join-points) and tests whether additional JPs are statistically signifi cant and should be added to the model. 17 The annual percentage change (APC) is calculated for each of these trends by means of a generalised linear model. Signifi cant changes include changes in direction or in the rate of increase or decrease. 18 The JP regression analyses were performed using Joinpoint Version 3.2 software obtained from the US National Cancer Institute. 15 
RESULTS
The present study focused only on the turning points and APC (Table 1) , rather than on real mortality rates. −7.89, −5.37 and −12.93, respectively. The APC characterises the trends of TB mortality rates in every slope. This means that rates were assumed to change at a constant percentage of the rate of the previous year. Between 1971 and 1987, the TB mortality rate dropped from 51 per 100 000 population to 13.4/ 100 000; during the following period (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) , the mortality rate dropped from 13.4 to 7/100 000, with a lower APC. From 2000 to 2008, the mortality decreased more rapidly, from 7 to 2.2/100 000, compared to the two previous stages. Interestingly, the three turning points closely refl ected the points of change in government structuring and organisational disease control measures, from the Bureau of TB Prevention in 1967 to the CDPT Bureau in 1988, then to the Taiwan CDC in 1999. Table 1 illustrates additional data from the JP regression analyses by sex and age group. Females had a higher APC in the two previous stages despite being in the younger age group (<45 years). Furthermore, the mortality rate in the younger group declined more during the fi rst turning point (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) , but did not show the same performance compared to the other two age groups.
DISCUSSION
Our study found changes in organisational structure that were associated with changes in the rate of decline of TB mortality among the population. This study assumed that organisational change would have a greater impact on TB mortality trends because TB control requires an enhanced programme that comprehensively integrates resources. Effective control of any infectious disease usually demands an organisation with a high level of dedication to combining resources from public health and other medical entities.
Campbell used designs of fi eld experiments to interpret different approaches to disease control. 19 Researchers used this method to determine whether programmes were effective and recognised outcomes that were based on immediate political implications. The mortality rate, for example, is an important index that is primarily used in the evaluation of TB control, as well as being basic and important information that identifi es serious issues in public health.
In general, numerous factors affected trends in mortality rates. In the majority of situations, factors related to reduction in mortality rates were improved nutrition, urbanisation, vaccination, medical treatment and public health. 20 For example, in public health, extensive health education assisted patients in developing a better understanding of TB and adherence to treatment schedules. 21 Declining trends in mortality in Taiwan have supported the assumed effectiveness of the above improvements, particularly during the initial stages of TB control. Developing countries should commit more funds to basic resources such as public health infrastructure and nutrition to build a strong foundation for TB control.
The study also gives valuable insight into mortality rates by sex and age group. Lu et al. found that the mortality rate in Taiwan increased with age, 22 along with the turning points' yearly trend. Checking the age effect, the ⩾65 years age group has two turning points, while the other two age groups have three. This means that the mortality trend for those aged ⩾65 years changed only once. However, according to the moving APC trend, organisational change affected the 45-64-year age group more signifi cantly than the other groups. The reason may be that TB prevention in the oldest group (⩾65 years) is more diffi cult due to comorbidies and other factors, whereas the youngest group (aged <45) received vaccines and medication. Does medication then affect mortality trends more signifi cantly than organisational change? TB chemotherapy positively affects population-based TB control efforts. In the past, more than 50% of TB patients died and 25% became chronically infectious due to a lack of effective medication and treatment. 23, 24 In 1972, rifampicin (RMP) and isoniazid were being widely used in TB treatment, and Taiwan started providing treatment free of charge, using medications (including RMP) to treat TB, in 1978. In 1990, the standard 6-month treatment regimen was introduced. With adequate treatment, the mortality rate reached a turning point, with a decreasing trend. However, this study did not observe these turning points during or after the above-mentioned periods. We cannot deny that treatment was a major contribution, with astonishing reductions in mortality rates in the fi rst stage (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) . However, TB control cannot rely solely on the use of medication; it also requires other public health efforts, which is the reason for the reversal of trends in the second stage.
Several other important TB control policies in Taiwan may be associated with the TB mortality rate (Table 2) . For example, BCG vaccination was implemented in 1951. From 1984, the authorities computerised the TB patient registry and case management, and National Health Insurance (NHI), launched in 1995, enhanced the completeness of TB reporting. Two years later, the no-notifi cation-no-reimbursement policy for unreported cases of active TB was introduced. 25 The Taiwan government also adopted a harm reduction programme for HIV and TB comorbidity that produced positive results. 26 However, these policies contributed little to the reduction in TB mortality rates. None of the aforementioned policies may have contributed more in changing the TB mortality rate than the organisational changes, as indicated in the Joinpoint regression.
Taiwan is a country of high population density and mobility, making case detection and management more diffi cult than if patients are treated in specialised TB clinics or hospitals. Some researchers worried over how organisational change from centralisation to decentralisation would affect TB control. 27 The results of this study showed that organisational changes correspond to turning points in TB mortality during the three stages illustrated in Figure 2 , which displays the mortality rates during these three stages.
Another possible challenge encountered is lost educational value. 28 An inexperienced doctor who encounters an uncommon case of TB in an individual case history now has reduced ability to learn clinical skills and must rely primarily on publications. 29 Instinct and experience still play a major part in determining whether treatment should be administered. 30 Further, the government needed to integrate that system into a full-scale contact investigation network, [31] [32] [33] rapid laboratory results, an effective vaccine and screening policy, and an effective treatment strategy such as DOTS, without which TB control in such a brief period would have been extremely diffi cult.
Taiwan's experience shows that TB control requires not only effective medical treatment but also fi rm political commitment. 34, 35 Historically, TB control operated independently in special programmes; in other words, the government combined personnel and budgets into an intensive operation. However, when the Bureau of TB Control ceased to exist, organisational change spread resources throughout the country, and the responsibility of TB control was transferred to the Chronic Disease Control Centers. The situation changed again after the Taiwan CDC was established, as CDC Taiwan received a larger budget for the TB control programmes. This study shows that organisational change had a greater effect on TB mortality trends, as TB control requires an enhanced programme that comprehensively integrates resources.
According to one study, 36 a single untreated TB patient can infect 10 to 15 persons. A successful TB programme needs political commitment. 37, 38 Without intensive strategies for contact investigation, protection, prevention and treatment, success in the fi ght against TB will be far more diffi cult in the future.
We now face more challenges, such as multidrugresistant TB (MDR-TB). The primary MDR-TB rate in Taiwan has increased from 0.2% in 1990 to the current 2.1%, a 10-fold increase in 10 years. 39 The public should be informed that TB is not a stigma, but a treatable, preventable disease. The key to TB control lies in early detection and treatment and in combining public health resources and medical entities with the intensity of purpose that we have learned from our lessons.
CONCLUSIONS
This study found that organisational structure and the availability of resources play an important role in TB control. We recommend that other countries consider these vital factors to enhance the effectiveness of TB control programmes. esta tasa disminuyó hasta 7 por 100 000 habitantes, con un menor porcentaje anual de cambio. Entre el 2000 y el 2008, el ritmo de la disminución de la mortalidad fue todavía más acelerado (de 7 por 100 000 a 2,2 por 100 000) que en los dos períodos previos. El análisis de regresión lineal segmentada permitió establecer la relación entre estos puntos de infl exión y las modifi caciones en la estructura de la organización del programa de control de la TB. C O N C L U S I Ó N : El presente estudio puso en evidencia la importante función que cumple la estructura organizativa y la disponibilidad de recursos en la lucha contra la TB. Se recomienda que otros países tengan en cuenta estos factores primordiales, con miras a reforzar la efi cacia de los programas de control de la enfermedad.
